-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Bicycle Therapeutics, Raises Price Target to $17

Benzinga·05/06/2025 14:22:57
Listen to the news
Morgan Stanley analyst Jeffrey Hung maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Equal-Weight and raises the price target from $15 to $17.